Mustang Bio Stock Target Price and Analyst Consensus

MBIO
 Stock
  

USD 0.47  0.027  5.40%   

The current analyst and expert consensus on Mustang Bio is Strong Buy, with 5 strong buy opinions. The current projected Mustang Bio target price consensus is 9.8 with 5 analyst opinions. The most common way Mustang Bio analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Mustang Bio executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Mustang Bio. We strongly encourage you to use your own analysis of Mustang Bio to validate this buy or sell advice. Mustang Bio buy-or-sell recommendation module provides average expert sentiment on the projected Mustang Bio target price to derive its highest and lowest estimates based on projected price volatility of 2.387. Additionally, see Macroaxis Advice on Mustang Bio to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  
Mustang Bio Interest Expense is quite stable at the moment as compared to the past year. The company's current value of Interest Expense is estimated at 15,394.74. Weighted Average Shares is expected to rise to about 94.8 M this year, although the value of Consolidated Income will most likely fall to (68.1 M).

Mustang Bio Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Mustang target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts performance other than comparing it to the past results via a very sophisticated attribution analysis. Mustang target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
Number of Opinions5
Lowered Outlook0
Raized Outlook0
Strong Buy
Most Mustang analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Mustang stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Mustang Bio, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Mustang Bio Target Price Projection

Mustang Bio's current and average target prices are 0.47 and 9.80, respectively. The current price of Mustang Bio is the price at which Mustang Bio is currently trading. On the other hand, Mustang Bio's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Mustang Bio Market Quote on 5th of December 2022

Low Price0.47Odds
High Price0.5Odds

0.473

Target Price

Analyst Consensus On Mustang Bio Target Price

Low Estimate7.0Odds
High Estimate13.0Odds
Number of Analysts5
Standard Deviation2.387

9.8

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Mustang Bio and the information provided on this page.

Mustang Bio Analyst Ratings

Mustang Bio's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Mustang Bio stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Mustang Bio's financials, market performance, and future outlook by experienced professionals. Mustang Bio's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Mustang Bio Target Price Projections

Mustang Bio's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Mustang Bio and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Mustang depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Mustang Bio including analysis of its current option contracts.
Mustang Bio's latest option contracts expiring on 2022-12-16 are carrying combined implied volatility of 91.2 with a put-to-call open interest ratio of 0.0 over 6 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2022-12-16. The current put volume is at 1, with calls trading at the volume of 6. This yields a 0.17 put-to-call volume ratio. The Mustang Bio option chain provides detailed quote and price information for the current Mustang Bio option contracts. It shows all of Mustang Bio's listed puts, calls, expiration dates, strike prices, and other pricing information.
Mustang Bio's stock options are financial instruments that give investors the right to buy or sell shares of Mustang Bio common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Mustang stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Mustang Bio's stock price goes up or down, the stock options follow.
Additionally, see Macroaxis Advice on Mustang Bio to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Mustang Current Options Market Mood

Mustang Bio's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Mustang Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Mustang Bio's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Mustang Bio's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Mustang Bio's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Additional Mustang Bio Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Mustang Bio is a key component of Mustang Bio valuation and have some predictive power on the future returns of a Mustang Bio.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Mustang Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Mustang Bio in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.030.515.10
Details
Intrinsic
Valuation
LowReal ValueHigh
0.142.817.40
Details
Earnings
Estimates (4)
LowProjected EPSHigh
-0.75-0.74-0.72
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Mustang Bio. Your research has to be compared to or analyzed against Mustang Bio's peers to derive any actionable benefits. When done correctly, Mustang Bio's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Mustang Bio.

Additional Mustang Bio Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Mustang Bio is a key component of Mustang Bio valuation and have some predictive power on the future returns of a Mustang Bio.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Mustang Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Mustang Bio in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.030.515.10
Details
Intrinsic
Valuation
LowReal ValueHigh
0.142.817.40
Details
Earnings
Estimates (4)
LowProjected EPSHigh
-0.75-0.74-0.72
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Mustang Bio. Your research has to be compared to or analyzed against Mustang Bio's peers to derive any actionable benefits. When done correctly, Mustang Bio's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Mustang Bio.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Technology
Invested over 20 shares
Impulse
Invested over 200 shares
Driverless Cars
Invested few shares
Investor Favorites
Invested over 60 shares
Corona Opportunity
Invested few shares
Macroaxis Index
Invested one share
Disruptive Technologies
Invested one share
Macroaxis Picks
Invested one share
Additionally, see Macroaxis Advice on Mustang Bio to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for analysis

When running Mustang Bio price analysis, check to measure Mustang Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mustang Bio is operating at the current time. Most of Mustang Bio's value examination focuses on studying past and present price action to predict the probability of Mustang Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Mustang Bio's price. Additionally, you may evaluate how the addition of Mustang Bio to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
The data published in Mustang Bio's official financial statements usually reflect Mustang Bio's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Mustang Bio. For example, before you start analyzing numbers published by Mustang accountants, it's critical to develop an understanding of what Mustang Bio's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Mustang Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Mustang Bio's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Mustang Bio's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Mustang Bio. Please utilize our Beneish M Score to check the likelihood of Mustang Bio's management to manipulate its earnings.